ArticleTherapeutic advances in musculoskeletal disease2021

Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib

Yue Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.